[HTML][HTML] Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity

SL Goldman, C Hassan, M Khunte, A Soldatenko… - Frontiers in …, 2019 - frontiersin.org
Leukemia, specifically acute myeloid leukemia (AML), is a common malignancy that can be
differentiated into multiple subtypes based on leukemogenic history and etiology. Although …

The genomics of acute myeloid leukemia in children

SE Conneely, RE Rau - Cancer and Metastasis Reviews, 2020 - Springer
Acute myeloid leukemia (AML) is a clinically, morphologically, and genetically
heterogeneous disorder. Like many malignancies, the genomic landscape of pediatric AML …

[HTML][HTML] An updated overview of the role of CYP450 during xenobiotic metabolization in regulating the acute myeloid leukemia microenvironment

C Sandoval, Y Calle, K Godoy, J Farías - International Journal of …, 2023 - mdpi.com
Oxidative stress is associated with several acute and chronic disorders, including
hematological malignancies such as acute myeloid leukemia, the most prevalent acute …

Acute myeloid leukemia

B Johansson, CJ Harrison - … Cytogenetics: Chromosomal and …, 2015 - Wiley Online Library
Acute leukemia is a worldwide disease with an incidence of approximately 4/100 000 per
year; 70% of the cases are acute myeloid leukemia (AML). The salient pathologic feature of …

Measurable residual disease testing for personalized treatment of acute myeloid leukemia

M Ehinger, L Pettersson - Apmis, 2019 - Wiley Online Library
This review summarizes–with the practicing hematologist in mind–the methods used to
determine measurable residual disease (MRD) in everyday practice with some future …

[HTML][HTML] Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study

BR Vundinti, S Korgaonkar, S Dhangar… - Journal of Cancer …, 2023 - journals.lww.com
Aims: The aim of the present study was to study the pattern and frequency of chromosomal
aberrations in acute myeloid leukemia (AML) subgroups from western India. Settings and …

Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4+ UK perspective

M Ruiz, K Jindal, V Casey, LM Soares… - Future …, 2024 - Taylor & Francis
Aim: To explore the incorporation of novel agents in the first-line setting for acute myeloid
leukemia patients. Materials & methods: Observational study based on data from a multi …

Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement

F Sameeta, SA Wang, Z Tang, JD Khoury… - American Journal of …, 2024 - academic.oup.com
Objectives We sought to characterize the immunophenotype of acute myeloid leukemia
(AML) with CBFB rearrangement and correlate the results with cytogenetic and molecular …

Acute myeloid leukemia with t (16; 16)(p13; q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology

F Albano, L Anelli, A Zagaria, N Coccaro, G Tota… - Human pathology, 2014 - Elsevier
Acute myeloid leukemia (AML) cases with inv (16)(p13q22) or t (16; 16)(p13; q22) are
characterized by multiple CBFB-MYH11 fusion transcripts, type A being the most frequent …

Acute myeloid leukemia with inv (16)(p13. 1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.

Z Mangaru, S Shetty, V Visconte, HD Liu… - American Journal of …, 2016 - europepmc.org
Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of
peripheral blood and bone marrow blasts. - Abstract - Europe PMC Sign in | Create an …